An open international multicentre long-term follow up study to evaluate safety of prolonged release OROS methylphenidate in adults with attention-deficit hyperactivity disorder.

Trial Profile

An open international multicentre long-term follow up study to evaluate safety of prolonged release OROS methylphenidate in adults with attention-deficit hyperactivity disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jun 2014

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Janssen Pharmaceutica; Janssen-Cilag
  • Most Recent Events

    • 30 Sep 2009 Company (Janssen-Cilag) added as trial sponsor and affiliate as reported by ClinicalTrials.gov (NCT00980499).
    • 30 Sep 2009 Company (Janssen-Cilag) added as trial sponsor and affiliate as reported by ClinicalTrials.gov (NCT00980499).
    • 25 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top